busulfan

(redirected from Myleran)
Also found in: Medical, Encyclopedia.

bu·sul·fan

 (byo͞o-sŭl′fən)
n.
An alkylating agent, C6H14O6S2, that is used as an antineoplastic drug in the treatment of chronic myelogenous leukemia.
[bu(tane) + alteration of sulfon(ate).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

busulfan

(bjuːˈsʌlfæn)
n
a drug used to treat cancer
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

busulfan

n busulfán m, busulfano (INN)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
[1] Similarly, Aspen, which is the dominant firm in the provision of Leukeran (chlorambucil), Alkeran (melphalan) and Myleran (busulfan) in SA, has seemingly taken advantage of their monopoly in the market and are under investigation for excessive pricing of these medicines.
Is there transparency in the pricing of medicines in the South African private sector?
Pharmaceutical company Mylan NV (NASDAQ:MYL)(TASE:MYL) and its Aspen (JSE:APN) partner revealed on Monday the availability of the US Food and Drug Administration (FDA) approved Myleran (busulfan) Injection in 60 mg/10 ml (6 mg/ml) single-dose vial in the US leukemia market.
Mylan & Aspen partnership unveils generic Busulfex Injection
The latter tolerates 6-400-fold higher concentration of various antineoplastic agents compared to humans (e.g., Amethopterin, Nitromin, Cytoxan, ThioTEPA, Myleran, Pactamycin, Carboplatin, Amsacrine, Thalicarpine, Chlorozotocin, and Fludarabine) [15].
Human induced pluripotent stem cell-derived cardiomyocytes afford new opportunities in inherited cardiovascular disease modeling
Dictionary browser ?
Full browser ?